Key result
Salvia miltiorrhiza injection significantly improved left ventricular systolic end pressure and left ventricular developed pressure in diabetic rats compared with no treatment.
RCT (n=30)
randomized
Salvia miltiorrhiza injection demonstrates myocardial protection in a rat model of diabetic cardiomyopathy, potentially mediated by downregulation of TSP-1 and TGF-β1.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for myocardial protection in diabetic cardiomyopathy; human trials required before any clinical consideration.
OBJECTIVES: To investigate the myocardially protective effects of Salvia miltiorrhiza injection in streptozotocin-induced diabetic rats and the possible mechanisms involved. METHODS: Adult male Sprague-Dawley rats were randomized into three groups (n = 10 per group): diabetes, no treatment (Sm-); diabetes, S. miltiorrhiza injection (Sm+); control (no diabetes; saline treatment). After model induction and 4 weeks' treatment, heart function of five rats from each group was tested by Langendorff isolated in vivo heart perfusion. In the remaining rats, pathological changes of the myocardium were observed by haematoxylin and eosin staining, and protein levels of thrombospondin-1 (TSP-1) and transforming growth factor-β1 (TGF-β1) were assessed by immunohistochemistry. RESULTS: Left ventricular systolic end pressure and left ventricular developed pressure were significantly improved in the Sm+ group compared with the Sm- group. Pathological changes were ameliorated through significantly reduced TSP-1 and TGF-β1 protein levels. CONCLUSIONS: S. miltiorrhiza injection may improve the heart function of diabetic rats and protect against cardiomyopathy by downregulating TSP-1 and TGF-β1 in myocardial tissue.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2012) conducted an RCT in streptozotocin-induced diabetes (n=30). Salvia miltiorrhiza injection vs. no treatment (diabetes) and saline treatment (no diabetes) was evaluated on Left ventricular systolic end pressure and left ventricular developed pressure. Salvia miltiorrhiza injection significantly improved left ventricular systolic end pressure and left ventricular developed pressure in diabetic rats compared with no treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: